Clinical Neurosciences Sc is categorized under Neurologists in Chicago, IL and active since 1994.
Clinical Neurosciences Sc was established in 1994, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Neurologists business, which does work in the B2C market, and is classified as a Neurologists, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Hilliard Slavick at the company’s single location by writing to 8 South Michigan Avenue # 1505, Chicago, Illinois IL 60603 or by phoning (312) 263-2828. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Clinical Neurosciences Sc |
| Contact Person: | Hilliard Slavick |
| Address: | 8 South Michigan Avenue # 1505, Chicago, Illinois 60603 |
| Phone Number: | (312) 263-2828 |
| Website Address: | clinneuro.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1994 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Neurologists |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Clinical Neurosciences Sc was started in 1994 to provide professional Neurologists under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Hilliard Slavick for inquiries that concern Clinical Neurosciences Sc by calling the company number (312) 263-2828, as your correspondence is most welcome. Additionally, the physical location of the single location of Clinical Neurosciences Sc can be found at the coordinates 41.881795,-87.624661 as well as the street address 8 South Michigan Avenue # 1505 in Chicago, Illinois 60603.
For its online presence, you may visit Clinical Neurosciences Sc’s website at clinneuro.com and engage with its social media outlets through on Twitter and on Facebook.